|
Free
Export controls, China's $100 billion chip push, and financial fragility could determine the fate of AI infrastructure spending.
|
Free
Comprehensive analysis of dilution arithmetic, semiconductor sector dispersion, and the technical levels defining Intel’s next move
|
Free
Australian policy shifts are second-order for tech valuations, yet any repricing in global rates ripples through growth equities.
|
Free
As biopharma shows, strong order books don't justify rich multiples unless backed by sustainable demand, margins, and cash conversion.
|
Free
As the Fed pauses and balance-sheet support fades, AI capex faces a more contested, data-dependent policy era.
